Status:
UNKNOWN
Determining the Clinical Utility of Using Virtual Reality Headsets to Assess Visual Function in Those With Glaucoma.
Lead Sponsor:
Queen's University, Belfast
Collaborating Sponsors:
University of Sussex
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Brief Summary
To validate a new virtual reality (VR) based visual field test against the gold standard clinical perimetry test (Humphrey Visual field test 24-2).
Detailed Description
Perimetry (or visual field testing) is a vision test used to evaluate a patient's peripheral vision. It involves a patient fixating on a central target and pressing a button when they see a spot of li...
Eligibility Criteria
Inclusion
- \- Patients with a clinical diagnosis of glaucoma with repeatable defects on standard automated perimetry.
Exclusion
- Presence of other ocular disease which impacts vision such as age-related macular degeneration or diabetic retinopathy.
- Any physical limitation that would make the participant unable to place their head in the head-rest to perform Humphrey Perimetry (Eg some patients with arthritic or neck problems are unable to use the headrests of ophthalmic devices).
- Any cognitive impairment that would limit their ability to perform perimetry or a history of vertigo/dizziness.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04273438
Start Date
October 1 2018
End Date
December 31 2020
Last Update
February 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NI Clinical Research Facility
Belfast, Northern Ireland, United Kingdom, BT9 7AB